Fatigue News and Research

RSS

Working memory may be underlying mechanism of cognitive reserve in MS

Kessler Foundation scientists have shown that working memory may be an underlying mechanism of cognitive reserve in multiple sclerosis (MS).

10 Sep 2014

Improper removal of personal protective gear increases risk for Ebola health care workers

A team of American infectious disease and critical care experts is alerting colleagues caring for Ebola patients that how they remove their personal protective gear can be just as crucial as wearing it to prevent exposure to the deadly virus.

10 Sep 2014

Lucideon announces collaboration with Knight Mechanical Testing

Lucideon, an international provider of materials development, testing and assurance, and Knight Mechanical Testing, an independent mechanical testing laboratory, are pleased to announce that they have entered into a Marketing and Commercial Collaboration Agreement. The agreement means that both partners will now be to offer a complete portfolio of testing and analysis services to the orthopaedic industry.

From Lucideon 10 Sep 2014

Researchers find that shared pain can boost actual group cooperation

What doesn't kill us may make us stronger as a group, according to findings from new research published in Psychological Science, a journal of the Association for Psychological Science.

10 Sep 2014

Researchers examine whether new drug offers added benefit for patients with chronic HCV

The drug simeprevir has been available since May 2014 for the treatment of adult patients with chronic hepatitis C infection.

9 Sep 2014

Ortho-oncology team successfully adapts shoulder surgical aid

An ortho-oncology team at Dartmouth-Hitchcock Norris Cotton Cancer Center successfully adapted a shoulder surgical aid (the Spider Limb Positioner) to conduct a left hip disarticulation on a melanoma patient as described in a case report published online in Medical Devices.

9 Sep 2014

FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

Silvergate Pharmaceuticals, Inc., focused on the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration approved Epaned for the treatment of symptomatic heart failure and the treatment of asymptomatic left ventricular dysfunction (to decrease the rate of development of overt heart failure and to reduce hospitalization for heart failure).

9 Sep 2014

Leading experts propose new treatment guidelines for chronic Lyme disease

Current treatments for Lyme disease, particularly chronic forms of the disease, are inadequate, according to a new treatment guideline written by a group of leading experts.

4 Sep 2014

Bristol-Myers Squibb launches Daklinza in the UK for treatment of chronic hepatitis C

Bristol-Myers Squibb today announced the launch of Daklinza▼ (daclatasvir) in the UK, a new medicine for the treatment of adult patients with chronic hepatitis C. Daclatasvir, a treatment that works across multiple hepatitis C genotypes, will allow up to 90% of UK patients the option of a potentially curative oral treatment regimen that does not include interferon, a standard of care commonly associated with sustained flu-like side effects.

4 Sep 2014

White pill may help scientists learn why patients with cystic fibrosis have less exercise capacity

A little white pill may help scientists learn why patients with cystic fibrosis have less exercise capacity than their peers, even if their lungs are relatively healthy.

3 Sep 2014

Yoga program for MS patients improves physical and mental well-being

Paula Meltzer was only 38 when out of nowhere everything she looked at was blurry. For the single mother, who had a lucrative career as a gemologist and spent hours examining valuable pieces of jewelry, it seemed as if - in a split second - her life changed.

3 Sep 2014

MEI Pharma completes patient enrollment in Pracinostat Phase II trial for treatment of MDS

MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that it has completed enrollment in a randomized Phase II clinical trial of its lead investigational drug candidate Pracinostat in combination with azacitidine in patients with previously untreated intermediate-2 or high-risk myelodysplastic syndrome (MDS).

2 Sep 2014

Intravenous iron supplement can improve quality of life for iron deficient heart failure patients

Heart failure patients with iron deficiency can experience significant and sustainable improvements in functional capacity and quality of life as well as reduced risk of hospital admission for worsening heart failure by receiving just one to two intravenous doses of an iron supplement, according to the results of a study presented today at ESC Congress 2014.

30 Aug 2014

MS study uses fNIRS to examine brain activation during working memory task

Using functional near infrared spectroscopy (fNIRS), Kessler Foundation researchers have shown differential brain activation patterns between people with multiple sclerosis (MS) and healthy controls.

30 Aug 2014

Initiatives to reduce deaths from heart failure for patients worldwide

The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) is calling for global policy change relating to heart failure. An international white paper, Heart failure: preventing disease and death worldwide, was published in May 2014.

30 Aug 2014

New technology holds potential to identify cardiac disease using video monitoring

To the careful observer, a person's face has long provided insight into what is going on beneath the surface. Now, with the assistance of a web camera and software algorithms, the face can also reveal whether or not an individual is experiencing atrial fibrillation, a treatable but potentially dangerous heart condition.

29 Aug 2014

Millions of women suffering in silence with hot flashes

The steep decline in the use of hormone therapy has spawned a prevalent but preventable side effect: millions of women suffering in silence with hot flashes, according to a study by a Yale School of Medicine researcher and colleagues.

28 Aug 2014

Experimental drug shows promise as viable treatment for anemia of inflammation

An experimental drug designed to help regulate the blood's iron supply shows promise as a viable first treatment for anemia of inflammation, according to results from the first human study of the treatment published online today in Blood, the Journal of the American Society of Hematology.

28 Aug 2014

Low dose of opioids including methadone effective for treatment of testosterone suppression

Treatment for opioid addiction tampers with the testosterone levels of male but not female opioid users, McMaster University research has shown.

26 Aug 2014

Persons with MS may be able to improve self-awareness via task-oriented cognitive rehabilitation

A new study of self-awareness by Kessler Foundation researchers shows that persons with multiple sclerosis (MS) may be able to improve their self-awareness through task-oriented cognitive rehabilitation.

25 Aug 2014

Fatigue News and Research

Working memory may be underlying mechanism of cognitive reserve in MS

Improper removal of personal protective gear increases risk for Ebola health care workers

Lucideon announces collaboration with Knight Mechanical Testing

Researchers find that shared pain can boost actual group cooperation

Researchers examine whether new drug offers added benefit for patients with chronic HCV

Ortho-oncology team successfully adapts shoulder surgical aid

FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

Leading experts propose new treatment guidelines for chronic Lyme disease

Bristol-Myers Squibb launches Daklinza in the UK for treatment of chronic hepatitis C

White pill may help scientists learn why patients with cystic fibrosis have less exercise capacity

Yoga program for MS patients improves physical and mental well-being

MEI Pharma completes patient enrollment in Pracinostat Phase II trial for treatment of MDS

Intravenous iron supplement can improve quality of life for iron deficient heart failure patients

MS study uses fNIRS to examine brain activation during working memory task

Initiatives to reduce deaths from heart failure for patients worldwide

New technology holds potential to identify cardiac disease using video monitoring

Millions of women suffering in silence with hot flashes

Experimental drug shows promise as viable treatment for anemia of inflammation

Low dose of opioids including methadone effective for treatment of testosterone suppression

Persons with MS may be able to improve self-awareness via task-oriented cognitive rehabilitation

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News